Skip to main content

Looking back on 2024: A year of hope and healing at UNC Lineberger

December 18, 2024
What does a year look like for the UNC Lineberger Comprehensive Cancer Center? Join us as we reflect on stories from 2024 that inspired us throughout the year.

Improving health of military personnel and families through collaboration, research

December 17, 2024
UNC Lineberger is leading an innovative cancer prevention partnership at Fort Liberty that is designed to reduce tobacco use and promote HPV vaccination.

Patient navigator brings relief and resilience to Avery County after Hurricane Helene

December 17, 2024
Annabella Cole, CCLS, partnered with the UNC Health oncology patient navigation team and community members to assemble and deliver 150 coping kits to children in western North Carolina.

HemOnc Today: Tamoxifen reduces ipsilateral recurrence risk for certain patients with DCIS

December 12, 2024

Healthcare Finance: UNC to establish AI-driven oncology center

December 12, 2024

Estrogen blocker drug following surgery may reduce the risk of DCIS recurrence

December 12, 2024
The research findings were reported by Jean Wright, MD, FASTRO, at the San Antonio Breast Cancer Symposium.

Medscape: Acalabrutinib Combo Promising as Frontline Treatment for CLL

December 11, 2024

International breast cancer meeting features UNC Lineberger research

December 10, 2024
More than 10,000 cancer researchers, clinicians and patient advocates from across the globe are expected to attend this year’s San Antonio Breast Cancer Symposium. The meeting will feature presentations by several UNC faculty members and trainees.

Pharmacy Practice News: Precision Oncology Effort Blooms in North Carolina

December 10, 2024

Peng, Xu published in Cancer Discovery

December 9, 2024
Researchers in the lab of Jen Jen Yeh, MD, have identified two kinotypes that differentiate the two established molecular subtypes pancreatic cancer, as reported in a paper published in Cancer Discovery.